|
|
Other links at Articles > Business of Medicine |
| 1. |
Tenet to Sell Broadlane Stake, Proceeds $155 Mln
|
|
|
Hospital operator Tenet Healthcare Corp said on Monday it will sell its interest in health care services company Broadlane Inc to TowerBrook Capital Partners L.P. for proceeds of about $155 million. Reuters Health Information
|
| 2. |
Melanoma Vaccine Study Misses Primary Goal
|
|
|
The late-stage trial of the metastatic melanoma vaccine Oncophage did not meet its primary goal of overall survival, vaccine maker Antigenics Inc said. Reuters Health Information
|
| 3. |
More Action Possible Erythropoiesis-Stimulating Agents: US FDA
|
|
|
U.S. regulators said on Thursday they were reviewing two recent studies that provided more evidence of serious risks for some cancer patients treated with erythropoiesis-stimulating agents, also known as ESAs or Epo drugs, for anemia. Reuters Health Information
|
| 4. |
U.S. FDA to Add 1,300 Staffers in Big Expansion
|
|
|
The U.S. Food and Drug Administration aims to hire more than 1,300 biologists, chemists, pharmacologists and other staff members by October as part of a major expansion, the agency said on Wednesday. Reuters Health Information
|
| 5. |
Stryker Recalls Some Artificial Hip Devices
|
|
|
Stryker Corp said on Tuesday it is recalling some artificial hip products made at its Cork, Ireland, facility because the devices did not meet company manufacturing standards. Reuters Health Information
|
|
|
